Literature DB >> 24345885

Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data.

J W Kim1, Y-J Jeon, D-H Baek, T N Kim, J S Chang.   

Abstract

UNLABELLED: Osteoporosis and high-risk osteopenia (high-risk of osteoporotic fractures) are highly prevalent in South Korean postmenopausal women and men aged 50 years and over.
INTRODUCTION: This study determined the percentages of the population at high risk of osteoporotic fractures according to the World Health Organization (WHO) criteria and the Fracture Risk Assessment (FRAX) model.
METHODS: Data collected from the 2010 Fifth Korean National Health and Nutrition Examination Survey, a cross-sectional survey of the general South Korean general population, were analyzed. The percentages of the population with high-risk osteopenia according to the US National Osteoporosis Foundation (NOF) and Japanese treatment guidelines were subsequently determined and compared.
RESULTS: Based on the WHO criteria and FRAX model, 37.7% of the menopausal women and 12.7% of the men aged 50 years and older are at high risk of osteoporotic fracture. According to the Japanese and NOF guidelines, 10.9 (10.6% of men and 11.2% of women) and 10.7% (10.6% of men and 10.9% of women), respectively, of the study population with osteopenia are at high risk of fracture. By age group, 49.3% of Korean women aged 55 years and older, 67.7% of Korean women aged 65 years and older, and 33.5% of Korean men aged 75 years and older are at high risk.
CONCLUSION: As a very large percentage of the South Korean postmenopausal population has osteoporosis or high-risk osteopenia, greater effort at identifying and treating this population should be expended to prevent osteoporotic fracture.

Entities:  

Mesh:

Year:  2013        PMID: 24345885     DOI: 10.1007/s00198-013-2595-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  17 in total

1.  American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update.

Authors:  Jeffrey I Mechanick; Pauline M Camacho; Rhoda H Cobin; Alan J Garber; Jeffrey R Garber; Hossein Gharib; Steven M Petak; Helena W Rodbard; Dace L Trence
Journal:  Endocr Pract       Date:  2010 Mar-Apr       Impact factor: 3.443

Review 2.  Osteoporosis.

Authors:  Philip Sambrook; Cyrus Cooper
Journal:  Lancet       Date:  2006-06-17       Impact factor: 79.321

3.  International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions.

Authors:  E Michael Lewiecki; Catherine M Gordon; Sanford Baim; Mary B Leonard; Nicholas J Bishop; Maria-Luisa Bianchi; Heidi J Kalkwarf; Craig B Langman; Horatio Plotkin; Frank Rauch; Babette S Zemel; Neil Binkley; John P Bilezikian; David L Kendler; Didier B Hans; Stuart Silverman
Journal:  Bone       Date:  2008-08-15       Impact factor: 4.398

4.  Prevalence, awareness, and treatment of osteoporosis among Korean women: The Fourth Korea National Health and Nutrition Examination Survey.

Authors:  Kyae Hyung Kim; Kiheon Lee; Young-Jin Ko; Seok Joong Kim; Soo Inn Oh; Daniel Y Durrance; Dahyun Yoo; Sang Min Park
Journal:  Bone       Date:  2012-02-16       Impact factor: 4.398

5.  Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures.

Authors:  Teresa A Hillier; Katie L Stone; Doug C Bauer; Joanne H Rizzo; Kathryn L Pedula; Jane A Cauley; Kristine E Ensrud; Marc C Hochberg; Steve R Cummings
Journal:  Arch Intern Med       Date:  2007-01-22

6.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

7.  The incidence and residual lifetime risk of osteoporosis-related fractures in Korea.

Authors:  Chanmi Park; Yong-Chan Ha; Sunmee Jang; Suhyun Jang; Hyun-Koo Yoon; Young-Kyun Lee
Journal:  J Bone Miner Metab       Date:  2011-06-07       Impact factor: 2.626

8.  Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.

Authors:  J Compston; A Cooper; C Cooper; R Francis; J A Kanis; D Marsh; E V McCloskey; D M Reid; P Selby; M Wilkins
Journal:  Maturitas       Date:  2009-01-08       Impact factor: 4.342

9.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

10.  Japanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary.

Authors:  Hajime Orimo; Toshitaka Nakamura; Takayuki Hosoi; Masayuki Iki; Kazuhiro Uenishi; Naoto Endo; Hiroaki Ohta; Masataka Shiraki; Toshitsugu Sugimoto; Takao Suzuki; Satoshi Soen; Yoshiki Nishizawa; Hiroshi Hagino; Masao Fukunaga; Saeko Fujiwara
Journal:  Arch Osteoporos       Date:  2012       Impact factor: 2.617

View more
  12 in total

1.  A cross-sectional study to examine the correlation between serum TSH levels and the osteoporosis of the lumbar spine in healthy women with normal thyroid function.

Authors:  H-M Noh; Y S Park; J Lee; W Lee
Journal:  Osteoporos Int       Date:  2014-09-25       Impact factor: 4.507

2.  A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians.

Authors:  Sung Ok Hong; Chae-Yoon Lee; Junho Jung; Deog-Yoon Kim; Christian Walter; Yong-Dae Kwon
Journal:  Clin Oral Investig       Date:  2016-10-22       Impact factor: 3.573

3.  Population-based, three-dimensional analysis of age- and sex-related femur shaft geometry differences.

Authors:  I J Jung; E J Choi; B G Lee; J W Kim
Journal:  Osteoporos Int       Date:  2021-01-26       Impact factor: 4.507

Review 4.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

Review 5.  Update on denosumab treatment in postmenopausal women with osteoporosis.

Authors:  Yong Ki Min
Journal:  Endocrinol Metab (Seoul)       Date:  2015-03-27

6.  Low Normal TSH levels are Associated with Impaired BMD and Hip Geometry in the Elderly.

Authors:  Su Jin Lee; Kyoung Min Kim; Eun Young Lee; Mi Kyung Song; Dae Ryong Kang; Hyeon Chang Kim; Yoosik Youm; Young Mi Yun; Hyun-Young Park; Chang Oh Kim; Yumie Rhee
Journal:  Aging Dis       Date:  2016-12-01       Impact factor: 6.745

7.  Change of Bone Mineral Density Measurement among Patients with Osteoporotic Fractures in Korean Population Using National Claim Database.

Authors:  Chan Ho Park; Young-Kyun Lee; Yong-Chan Ha
Journal:  J Bone Metab       Date:  2017-08-31

8.  Status of bone health and association of socio-demographic characteristics with Bone Mineral Density in Pakistani Females.

Authors:  Saba Tariq; Mukhtiar Baig; Sundus Tariq; Muhammad Shahzad
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

9.  Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension.

Authors:  Jung Min Koh; Dong Jin Chung; Yoon Sok Chung; Moo Il Kang; In Ju Kim; Yong Ki Min; Han Jin Oh; Il Hyung Park; Yil Seob Lee; Barbara Kravitz; Brian Waterhouse; Antonio Nino; Lorraine A Fitzpatrick
Journal:  Yonsei Med J       Date:  2016-07       Impact factor: 2.759

10.  The efficacy and safety of herbal medicine BHH10 in postmenopausal women with osteoporosis: study protocol for a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial.

Authors:  Yeeun Cho; Seunghoon Lee; Jihye Kim; Jung Won Kang; Yong-Hyeon Baek; Byung-Kwan Seo; Jae-Dong Lee
Journal:  Trials       Date:  2018-09-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.